Clinical Trials Sponsored by Endeavor Biomedicines, Inc.
Total 22 results
-
Endeavor Biomedicines, Inc.Not yet recruitingIdiopathic Pulmonary Fibrosis | Progressive Fibrosing Interstitial Lung Disease | Progressive Pulmonary FibrosisUnited States, Switzerland, Canada, Australia, Austria, United Kingdom, Malaysia, Mexico, Germany, Ireland, Korea, Republic of
-
Endeavor Biomedicines, Inc.CompletedIdiopathic Pulmonary FibrosisCanada, Malaysia, Australia, Mexico, Korea, Republic of
-
Endeavor Biomedicines, Inc.Active, not recruitingSolid Tumors With PTCH1 Loss-of-function MutationsUnited States
-
Endeavor Biomedicines, Inc.CompletedIdiopathic Pulmonary FibrosisAustralia
-
GAIA BioMedicine Inc.Recruiting
-
Eisai Inc.H3 Biomedicine Inc.TerminatedLymphoma | Advanced Solid TumorsUnited States, Spain, France, Korea, Republic of, United Kingdom
-
H3 Biomedicine Inc.Eisai Inc.CompletedLiver Neoplasms | Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | Liver Cancer | Hepatic Cancer | Hepatic CarcinomaFrance, United States, Belgium, Spain, Taiwan, Korea, Republic of, Russian Federation, Canada, Italy, Singapore, United Kingdom
-
Eisai Inc.H3 Biomedicine Inc.Withdrawn
-
Eisai Inc.H3 Biomedicine Inc.Completed
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia VeraAustralia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedHealthy Volunteers | Hepatic ImpairmentUnited States
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompleted
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationAvailable
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedHealthy VolunteersUnited States
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedHealthy VolunteersUnited States
-
Fundacion para la Innovacion en Biomedicina (FIBMED)Biosense Webster, Inc.Active, not recruitingPersistent Atrial FibrillationSpain
-
Noah MerinTeva Branded Pharmaceutical Products R&D, Inc.; Miltenyi Biomedicine GmbHActive, not recruitingLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | CLLUnited States
-
Ilaria ColomboEnte Ospedaliero Cantonale, Bellinzona; Institute for Research in BiomedicineCompletedCancer | Covid19Switzerland
-
Ricardo Pereira MestreOncology Institute of Southern Switzerland; Institute of Oncology Research; Institute...TerminatedCOVID-19 InfectionSwitzerland
-
Maria Betânia Almeida Dias FerreiraCentral Hospital, Nancy, France; Instituto de Ciências Biomédicas Abel Salazar and other collaboratorsCompletedCardiovascular Diseases | Heart Failure | Rheumatoid Arthritis | Cardiovascular Risk Factor | Myocardium; Injury
-
Fundación Pública Andaluza para la Investigación...Instituto de Salud Carlos III; Spanish Biomedical Research Centre in Diabetes...Completed